Shintaro Ogawa

797 total citations
32 papers, 446 citations indexed

About

Shintaro Ogawa is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Shintaro Ogawa has authored 32 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 24 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Shintaro Ogawa's work include Hepatitis C virus research (23 papers), Hepatitis B Virus Studies (22 papers) and Liver Disease Diagnosis and Treatment (18 papers). Shintaro Ogawa is often cited by papers focused on Hepatitis C virus research (23 papers), Hepatitis B Virus Studies (22 papers) and Liver Disease Diagnosis and Treatment (18 papers). Shintaro Ogawa collaborates with scholars based in Japan, United States and Bangladesh. Shintaro Ogawa's co-authors include Yasuhito Tanaka, Etsuko Iio, Kentaro Matsuura, Shuko Murakami, Noboru Shinkai, Shigeru Kusumoto, Takanori Suzuki, Takako Inoue, Hidenori Toyoda and Katsumi Aoyagi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Shintaro Ogawa

27 papers receiving 444 citations

Peers

Countries citing papers authored by Shintaro Ogawa

Since Specialization

Citations

This map shows the geographic impact of Shintaro Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shintaro Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shintaro Ogawa more than expected).

Fields of papers citing papers by Shintaro Ogawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shintaro Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shintaro Ogawa. The network helps show where Shintaro Ogawa may publish in the future.

Co-authorship network of co-authors of Shintaro Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shintaro Ogawa. A scholar is included among the top collaborators of Shintaro Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shintaro Ogawa. Shintaro Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical performance of Circulating HBV RNA and iTACT‐HBcrAg Assays in HBeAg‐negative and HBsAg‐cleared Chronic Hepatitis B Patients 2024 ·Journal of Medical Virology ·Takanori Suzuki, (unknown), Takako Inoue, (unknown), Shintaro Ogawa, Takehisa Watanabe, (unknown), Kei Fujiwara, Hiromi Kataoka, Yasuhito Tanaka	0
2	MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents 2024 ·Journal of Gastroenterology ·Takanori Suzuki, Kentaro Matsuura, (unknown), Kyoko Ito, Shintaro Ogawa, (unknown), Kei Fujiwara, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka	0
3	Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents 2024 ·Oncology ·Takanori Suzuki, Kentaro Matsuura, (unknown), (unknown), Kei Fujiwara, Shintaro Ogawa, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka	2
4	3D Semantic Mapping based on RGB-D Camera and LiDAR Sensor in Beach Environment 2024 ·(unknown), Shintaro Ogawa, (unknown), (unknown), (unknown), Eiji Hayashi	1
5	Multi-omics analysis using antibody-based in situ biotinylation technique suggests the mechanism of Cajal body formation 2024 ·Cell Reports ·Keisuke Noguchi, (unknown), Ryota Abe, Keiko Horiuchi, (unknown), Nobuyoshi Akimitsu, Shintaro Ogawa, Tomohiko Akiyama, (unknown), Yoko Ino, Yayoi Kimura, Akihide Ryo, Hiroshi Doi, Fumiaki Tanaka, Yutaka Suzuki, Atsushi Toyoda, Yuki Yamaguchi, Hidehisa Takahashi	1
6	Serum inducible protein 10 kDa/C‐X‐C motif chemokine 10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents 2023 ·Hepatology Research ·(unknown), Takanori Suzuki, Kentaro Matsuura, Shintaro Ogawa, (unknown), (unknown), Kei Fujiwara, Shunsuke Nojiri, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka	3
7	The BCRobo dataset for Robotic Vision and Autonomous Path Planning in Outdoor Beach Environment 2023 ·Proceedings of International Conference on Artificial Life and Robotics ·(unknown), (unknown), (unknown), Shintaro Ogawa, (unknown), (unknown), Eiji Hayashi	0
8	MED26‐containing Mediator may orchestrate multiple transcription processes through organization of nuclear bodies 2023 ·BioEssays ·(unknown), (unknown), Ryota Abe, Shintaro Ogawa, Sayaka Ito, Tomohiko Akiyama, Keiko Horiuchi, Hidehisa Takahashi	2
9	Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation 2022 ·Journal of Gastroenterology ·Takanori Suzuki, Takako Inoue, (unknown), Shigeru Kusumoto, (unknown), Shintaro Ogawa, Shintaro Yagi, Atsushi Kaneko, Kei Fujiwara, Takehisa Watanabe, Katsumi Aoyagi, Yukitomo Urata, Akihiro Tamori, Hiromi Kataoka, Yasuhito Tanaka	10
10	Characterization of innate immune response to hepatitis B virus genotype F acute infection in tree shrew (Tupaia belangeri) model 2022 ·SHILAP Revista de lepidopterología ·Mohammad Enamul Hoque Kayesh, (unknown), Takahiro Sanada, (unknown), (unknown), (unknown), Sayeh Ezzikouri, Shuko Murakami, Shintaro Ogawa, Yasuhito Tanaka, Michinori Kohara, Kyoko Tsukiyama–Kohara	1
11	Blocking neddylation elicits antiviral effect against hepatitis B virus replication 2021 ·Molecular Biology Reports ·(unknown), Mohammad Enamul Hoque Kayesh, Haya Altawalah, (unknown), Shuko Murakami, Shintaro Ogawa, Yasuhito Tanaka, Hind Dehbi, Pascal Pineau, Michinori Kohara, Soumaya Benjelloun, Kyoko Tsukiyama–Kohara, Sayeh Ezzikouri	4
12	Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation 2021 ·Journal of Hepatology ·Takako Inoue, Shigeru Kusumoto, Etsuko Iio, Shintaro Ogawa, Takanori Suzuki, Shintaro Yagi, Atsushi Kaneko, Kentaro Matsuura, Katsumi Aoyagi, Yasuhito Tanaka	70
13	Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection 2021 ·PLoS ONE ·Takanori Suzuki, Kentaro Matsuura, (unknown), Etsuko Iio, Shintaro Ogawa, Kei Fujiwara, Shunsuke Nojiri, Hiromi Kataoka, Yasuhito Tanaka	8
14	Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNA 2020 ·Virus Research ·Mohammad Enamul Hoque Kayesh, Yutaka Amako, (unknown), Shuko Murakami, Shintaro Ogawa, Naoki Yamamoto, (unknown), Noriaki Miyoshi, Masaya Sugiyama, Yasuhito Tanaka, Masashi Mizokami, Michinori Kohara, Kyoko Tsukiyama–Kohara	26
15	Factors associated with longitudinal changes in serum concentrations of Mac-2 binding protein: A prospective 3-year observational study 2019 ·Nutrition Metabolism and Cardiovascular Diseases ·Tomonori Sugiura, Yasuaki Dohi, Hiroyuki Takase, Sumiyo Yamashita, (unknown), Shintaro Ogawa, Yasuhito Tanaka, Nobuyuki Ohte	8
16	Serial changes of NS5A P32deletion mutant in HCV genotype 1b patients after Daclatasvir/Asunaprevir failure 2018 ·Kanzo ·Etsuko Iio, Shintaro Ogawa, Noritomo Shimada, Yuichiro Eguchi, Noboru Hirashima, Kentaro Matsuura, Yasuhito Tanaka	2
17	High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues 2017 ·Journal of Gastroenterology ·Noboru Shinkai, Masanori Nojima, Etsuko Iio, (unknown), Hidenori Toyoda, Shuko Murakami, Takako Inoue, Shintaro Ogawa, Takashi Kumada, Yasuhito Tanaka	31
18	Serum levels of Mac-2 binding protein increase with cardiovascular risk and reflect silent atherosclerosis 2016 ·Atherosclerosis ·Tomonori Sugiura, Yasuaki Dohi, Hiroyuki Takase, Sumiyo Yamashita, Shunsuke Murai, (unknown), Shintaro Ogawa, Yasuhito Tanaka, Nobuyuki Ohte	30
19	Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens 2015 ·PLoS ONE ·Nobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, Hitomi Takada, Natsuko Nakakuki, Yutaka Yasui, Shōko Suzuki, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Shintaro Ogawa, Yasuhito Tanaka, Yasuhiro Asahina, Namiki Izumi	19
20	Genetic Association of Human Leukocyte Antigens with Chronicity or Resolution of Hepatitis B Infection in Thai Population 2014 ·PLoS ONE ·Nawarat Posuwan, Sunchai Payungporn, Pisit Tangkijvanich, Shintaro Ogawa, Shuko Murakami, Sayuki Iijima, Kentaro Matsuura, Noboru Shinkai, Tsunamasa Watanabe, Yong Poovorawan, Yasuhito Tanaka	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact